JAN 29, 2016 5:22 PM PST

Blood Pressure Drug May Be Answer to Alzheimer's Disease

WRITTEN BY: Julianne Chiaet
Alzheimer's disease primarily affects individuals over age 65.A drug used to treat high blood pressure could be the answer to treating and preventing Alzheimer’s disease.

Alzheimer’s disease is a progressive degenerative brain disease. It causes cognitive decline and memory loss. In Alzheimer’s disease, damaged cells release too much glutamate, an important neurotransmitter involved in most aspects of brain function. The excess glutamate leads to chronic overexposure to calcium, which in turn speeds up brain cell damage.

Using neuronal cultures, the researchers studied the effects of the high blood pressure medication on the toxic effects of excessive glutamate. The medication, candesartan, is an angiotensin receptor blocker sold under the brand name Atacand.

The researchers found that candesartan prevented neuronal death caused by glutamate. The drug also prevented neuronal inflammation and changes in amyloid metabolism. The latter change is especially important since the buildup of amyloid plaques are a hallmark of the disease. The researchers then compared the gene expression in the cultures to autopsy samples from Alzheimer’s patients that were published in gene databases.
 

"The correlations were impressive. The expression of 471 genes that were altered by excess glutamate in our cultures were also altered in brain autopsy samples from patients who suffered from Alzheimer's disease. Candesartan normalized expression of these genes in our cultures," said study author Abdel G. Elkahloun, from the Comparative Genomics and Cancer Genetics Branch of the National Human Genome Research Institute.

The researchers hypothesize that candesartan and/or other angiotensin receptor blockers have the potential to slow down the progression of Alzheimer’s and prevent or delay its development.
They say their findings support testing candesartan and other angiotensin receptor blockers in controlled clinical studies on patients at early stages of Alzheimer’s.

The research was published online on January 28, 2016, in the journal Alzheimer’s Research and Therapy.

Sources: Journal study Alzheimer’s Research and Therapy, Georgetown University Medical Center press release

 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
AUG 26, 2021
Health & Medicine
Hoover Dam is going dry: Water shortage declared for the first time ever in the USA
AUG 26, 2021
Hoover Dam is going dry: Water shortage declared for the first time ever in the USA
We have all heard of the famous “bathtub ring” around Lake Mead (AZ, MN) and many have seen photos and video ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
AUG 31, 2021
Health & Medicine
Your metabolism does slow down as you age, but not until you're over 60
AUG 31, 2021
Your metabolism does slow down as you age, but not until you're over 60
A new study shows that, yes, your metabolism does slow down as you age, but not until you're over 60
SEP 01, 2021
Clinical & Molecular DX
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
SEP 01, 2021
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
Patients are seven times more likely to have a heart attack or stroke than the general population after receiving treatm ...
SEP 11, 2021
Genetics & Genomics
New NIH Consortium Aims to Understand the Impact of Genetic Variants
SEP 11, 2021
New NIH Consortium Aims to Understand the Impact of Genetic Variants
Scientists sequenced most of the human genome abut two decades ago. It took many years to complete the project because o ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
Loading Comments...